Whats New

Informational Links & Pages on the left.
Search, Subscribe, General Info, Take A Poll on the right.
Articles & Posts Appear Below The Welcome


Up-to-the-Second Site Activity:

Latest MyQuinStory Facebook Posts:

www.myquinstory.info/returning-from-the-brink/ ... See MoreSee Less

View on Facebook

I am very thankful to those who worked with Nature to produce this well written article. Nature, the International Journal of Science at Nature.com, is a well respected journal and will garner some much needed attention.

I am also humbled that My Quin Story was referenced along with briefly mentioning my personal FQAD case when discussing Dr. Beatrice Golomb UCSD's research into FQAD, let's hope this opens some more doorways for research and awareness.

Keep up the good work!

... See MoreSee Less

View on Facebook

From reporter Kerri O'Brien, WRIC...

... See MoreSee Less

View on Facebook

The European Medicines Agency (EMA) has announced that its Pharmacovigilance Risk Assessment Committee (PRAC) will hold a public hearing on quinolone and fluoroquinolone antibiotics, as part of an ongoing safety review into the drugs.

The hearing on quinolones and fluoroquinolones is due to take place at the PRAC meeting in June 2018. It marks only the second time that the PRAC has held such a hearing during a safety review.


... See MoreSee Less

View on Facebook

Omaveloxolone is an oral, once-daily Nrf2 activator in clinical development.Nrf2 leads to the expression of genes that improve mitochondrial function. Preclinical studies showed that omaveloxolone increases the number of mitochondria and their energy production.Nrf2 activation also blocks inflammation and protects against oxidative stress.

... See MoreSee Less

View on Facebook




...damaged by fluoroquinolones in 2007 at age 46. Prior to, a healthy law enforcement official. Now an amateur FQ researcher, author, and blogger.